发明名称 Polynucleotide therapy
摘要 The invention provides a method of treating or preventing a disease in an animal associated with one or more self-protein(s), -polypeptide(s), or -peptide(s) that is present or involved in a non-physiologic process in the animal comprising administering to the animal a self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) associated with the disease. Administration of the self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) modulates an immune response to the self-protein(s), -polypeptide(s) or -peptide(s) expressed from administration of the self-vector. The invention also provides a composition comprising a polynucleotide encoding one or more self-protein(s), -polypeptide(s), or -peptide(s) that is present non-physiologically in a treated animal useful in treating or preventing a disease associated with the self-protein(s), - polypeptide(s), or -peptide(s) present in and/or the target of a non-physiologic process in the animal.
申请公布号 EP2301552(A1) 申请公布日期 2011.03.30
申请号 EP20100178426 申请日期 2002.11.21
申请人 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 发明人 FONTOURA, PAULO;GARREN, HIDEKI;ROBINSON, WILLIAM, H.;STEINMAN, LAWRENCE;RUIZ, PEDRO JOSE;UTZ, PAUL J.
分类号 A61K31/70;C12N15/09;A61K38/20;A61K39/00;A61K48/00;A61P1/16;A61P3/04;A61P3/10;A61P5/48;A61P19/00;A61P19/02;A61P25/00;A61P25/16;A61P25/28;A61P29/00;A61P37/00 主分类号 A61K31/70
代理机构 代理人
主权项
地址